Table 4 Multivariate analysis of possible risk factors for type 1 gastric NET recurrence
From: Management of type 1 gastric neuroendocrine tumors: an 11-year retrospective single-center study
Factor | HR (95% CI) | P* |
|---|---|---|
Sex | ||
Male | 1 | |
Female | 0.53 (0.32–0.88) | 0.014 |
Maximum diameter of tumor (cm) | ||
< 0.5 | 1 | |
0.5–0.9 | 1.59 (0.83–3.06) | 0.163 |
1.0–1.9 | 2.72 (1.27–5.81) | 0.010 |
≥ 2.0 | 2.65 (0.93–7.53) | 0.068 |
Endoscopic treatment | ||
No | 1 | |
Yes | 2.47 (0.88–6.93) | 0.085 |
TCM treatment | ||
No | 1 | |
Yes | 0.55 (0.31–0.99) | 0.046 |